Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Ранг среди акций #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Цена акции
$0.11725176
Последняя синхронизация: 2025-07-14
Рыночная капитализация
$481.50K
Изменение (1 день)
-0.20%
Изменение (1 год)
0.00%
Страна
FR
Торговля PHAXIAM Therapeutics S.A. (PHXM)

Категория

EPS для PHAXIAM Therapeutics S.A. (PHXM)
EPS по состоянию на June 2024 TTM: $-4.23
Согласно последним финансовым отчетам и цене акций PHAXIAM Therapeutics S.A., текущий EPS компании (TTM) составляет $-4.23. В конце 2022 EPS компании составлял $-0.07, меньше, чем показателю 2021 года, равному $-23.87.
История EPS компании PHAXIAM Therapeutics S.A. с 2016 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -509.44%
US
$27.74 -755.76%
NL
- -
CH
- -
KR
$13.70 -423.86%
BE